FDA Inspection
Akorn, Inc.Akorn, Inc. – FDA Inspection, Nov 10, 2009
Record Details
This FDA Inspection record concerns Akorn, Inc., with an inspection on November 10, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Akorn, Inc.
- Inspection Date
- November 10, 2009
- Product Type
- Drugs
View Company Profile
ID · 9148056f-03bd-4066-9193-12341fea1825
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 629551
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
- 21 CFR 211.198(a)Complaint Handling Procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Akorn, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 20, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 18, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Akorn, Inc.
- FDA Inspection 1085157 - 2019-03-05
- FDA Inspection 1012412 - 2017-03-20
- FDA Inspection 1004511 - 2017-02-13
- FDA Inspection 950673 - 2015-12-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.